BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2227792)

  • 1. [Plasma prostaglandin E2 and skin graft rejection in the rat].
    Tanaka Y
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):403-11. PubMed ID: 2227792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
    J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early markers of pancreas transplant rejection.
    Zheng T; Lu Z; Merideth N; Lanza RP; Soon-Shiong P
    Am Surg; 1992 Oct; 58(10):630-3. PubMed ID: 1384408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejection.
    Zehr KJ; Herskowitz A; Lee PC; Poston RS; Gillinov AM; Baumgartner WA
    J Heart Lung Transplant; 1993; 12(5):837-44; discussion 844-5. PubMed ID: 8241225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of prostaglandin receptors (EPR2-4) in in vivo immunosuppression of PGE2 in rat skin transplant model.
    Fujimoto Y; Iwagaki H; Ozaki M; Ogino T; Murata H; Sun DS; Sadamori H; Takahashi HK; Tanaka N; Yagi T
    Int Immunopharmacol; 2005 Jul; 5(7-8):1131-9. PubMed ID: 15914318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation in urinary prostaglandin (PGE2) as an early marker of pancreas allograft rejection.
    Soon-Shiong P; Zheng TL; Merideth N; Chang YH
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2771-3. PubMed ID: 2650361
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerance to cardiac allografts induced in utero with fetal liver cells.
    Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
    Circulation; 1996 Nov; 94(9 Suppl):II304-7. PubMed ID: 8901765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGG-glucan, a leukocyte-specific immunostimulant, does not potentiate GVHD or allograft rejection.
    Washburn WK; Otsu I; Gottschalk R; Monaco AP
    J Surg Res; 1996 May; 62(2):179-83. PubMed ID: 8632636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Involvement of ICAM-1/LFA-1 adhesion molecule set in rat orthotopic liver transplantation].
    Omura T
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1220-31. PubMed ID: 7868060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal versus systemic venous drainage for small-bowel allografts.
    Schraut WH; Abraham VS; Lee KK
    Surgery; 1985 Sep; 98(3):579-86. PubMed ID: 3875908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of indirect donor-specific hyporesponsiveness by transportal RT1-peptide pulse in rat skin transplantation.
    Yamamura M; Yagi T; Iwagaki H; Mitsuoka N; Jie L; Sheng SD; Matsuda H; Sadamori H; Inagaki M; Tanaka N
    Transpl Int; 2003 Aug; 16(8):451-5. PubMed ID: 12719799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterotopic limb allotransplantation model to study skin rejection in the rat.
    Nazzal JA; Johnson TS; Gordon CR; Randolph MA; Lee WP
    Microsurgery; 2004; 24(6):448-53. PubMed ID: 15499552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of serum class I antigen in allograft recipient rats--origin and control of serum class I antigen.
    Sumimoto R; Fukuda Y; Shinomiya T; Asahara T; Dohi K
    Hiroshima J Med Sci; 1998 Jun; 47(2):39-45. PubMed ID: 9674339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2.
    Gorczynski RM; Fu XM; Issekutz T; Cohen Z
    Cell Immunol; 1998 Feb; 184(1):74-82. PubMed ID: 9626338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts.
    Tavakoli R; Gazdhar A; Pierog J; Bogdanova A; Gugger M; Pringle IA; Gill DR; Hyde SC; Genoni M; Schmid RA
    J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.